Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Andrew Hantel, M.D.

Profile Picture

Loyola University Chicago, Chicago, ILMD06/2013
University of Chicago, Chicago, IL06/2016Internal Medicine Residency
University of Chicago, Chicago, IL06/2016Medical Ethics Fellowship
University of Chicago, Chicago, IL06/2019Hematology/Oncology Fellowship
Dana-Farber Cancer Institute, Boston, MA06/2021Population Science Post-doctoral Fellowship

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K08CA273043-01 (Hantel, Andrew) Jul 1, 2022 - Jun 30, 2027
    Diversifying Acute Leukemia Clinical Trial Enrollment Through Multilevel Intervention
  2. Making a Difference Grant (Hantel, Andrew) Jul 1, 2022 - Jun 30, 2024
    Greenwall Foundation
    Developing Practical Guidance for Integrating Sustainability and Conservation Ethics into Clinical Decision-Making
  3. Special Projects Fund (Hantel, Andrew) Jul 1, 2021 - Jun 30, 2023
    Alliance for Clinical Trials in Oncology
    Development and Piloting of a Novel Provider Feedback Intervention to Improve Clinical Trial and Biobank Enrollment Diversity

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Hantel A, Clancy DD, Kehl KL, Marron JM, Van Allen EM, Abel GA. A Process Framework for Ethically Deploying Artificial Intelligence in Oncology. J Clin Oncol. 2022 Jul 18; JCO2201113. PMID: 35849792.
    Citations:    Fields:    
  2. Hantel A, Kohlschmidt J, Eisfeld AK, Stock W, Jacobson S, Mandrekar S, Larson RA, Stone RM, Lathan CS, DeAngelo DJ, Byrd JC, Abel GA. Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention. J Clin Oncol. 2022 Jun 13; JCO2200307. PMID: 35696629.
    Citations:    Fields:    
  3. Hantel A, McManus ML, Wadleigh M, Cotugno M, Abel GA. Impact of Allocation on Survival During Intermittent Chemotherapy Shortages: A Modeling Analysis. J Natl Compr Canc Netw. 2022 04; 20(4):335-341.e17. PMID: 35390765.
    Citations:    Fields:    Translation:Humans
  4. Hantel A, Luskin MR, Garcia JS, Stock W, DeAngelo DJ, Abel GA. Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. Blood Adv. 2021 11 09; 5(21):4352-4360. PMID: 34473244.
    Citations: 1     Fields:    Translation:Humans
  5. Abel GA, Klepin HD, Magnavita ES, Jaung T, Lu W, Shallis RM, Hantel A, Bahl NE, Dellinger-Johnson R, Winer ES, Zeidan AM. Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes. Transfusion. 2021 10; 61(10):2830-2836. PMID: 34251040.
    Citations:    Fields:    Translation:Humans
  6. Abel GA, Kim HT, Hantel A, Steensma DP, Stone R, Habib A, Ho VT, Wadleigh M, El-Jawahri A, Alyea EP, DeAngelo DJ, Koreth J, Antin JH, Soiffer RJ, Cutler C. Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Leukemia. 2021 Apr; 35(4):1223. PMID: 33487633.
    Citations:    Fields:    
  7. Hantel A, Peppercorn J, Abel GA. Model solutions for ethical allocation during cancer medicine shortages. Lancet Haematol. 2021 04; 8(4):e246-e248. PMID: 33770477.
    Citations:    Fields:    Translation:Humans
  8. Hantel A, Marron JM, Casey M, Kurtz S, Magnavita E, Abel GA. US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer. JAMA Oncol. 2021 02 01; 7(2):199-205. PMID: 33270132.
    Citations: 4     Fields:    Translation:HumansCells
  9. Hantel A, DuMontier C, Odejide OO, Luskin MR, Sperling AS, Hshieh T, Chen R, Soiffer R, Driver JA, Abel GA. Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Cancer. 2021 03 15; 127(6):875-883. PMID: 33237587; PMCID: PMC7946649.
    Citations: 1     Fields:    Translation:Humans
  10. Abel GA, Kim HT, Hantel A, Steensma DP, Stone R, Habib A, Ho VT, Wadleigh M, El-Jawahri A, Alyea EP, DeAngelo DJ, Koreth J, Antin JH, Soiffer RJ, Cutler C. Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Leukemia. 2021 04; 35(4):1166-1175. PMID: 33204012.
    Citations: 1     Fields:    Translation:Humans
  11. Hantel A, Hlubocky FJ, Siegler M, Daugherty CK. A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed. JCO Oncol Pract. 2020 10; 16(10):e1098-e1111. PMID: 32469685.
    Citations:    Fields:    Translation:Humans
  12. Hantel A, Abel GA. An Action Plan for Environmentally Sustainable Cancer Care. JAMA Oncol. 2020 04 01; 6(4):469-470. PMID: 32027350.
    Citations:    Fields:    Translation:HumansPHPublic Health
  13. Hantel A, Egan AM, Nguyen TT, DeMartino ES, Hlubocky F, Bastow S, Siegler M, Daugherty CK. A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages. J Grad Med Educ. 2020 Feb; 12(1):38-43. PMID: 32089792; PMCID: PMC7012528.
    Citations: 1     Fields:    Translation:Humans
  14. Balagopal V, Hantel A, Kadri S, Steinhardt G, Zhen CJ, Kang W, Wanjari P, Ritterhouse LL, Stock W, Segal JP. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing. PLoS One. 2019; 14(10):e0224097. PMID: 31658273; PMCID: PMC6816574.
    Citations: 6     Fields:    Translation:HumansCells
  15. Hantel A, Abel GA, Siegler M. Practical allocation system for the distribution of specialised care during cellular therapy access scarcity. J Med Ethics. 2019 08; 45(8):532-537. PMID: 31217227.
    Citations: 1     Fields:    Translation:Humans
  16. Hantel A, Siegler M, Hlubocky F, Colgan K, Daugherty CK. Prevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists. JAMA Intern Med. 2019 05 01; 179(5):710-711. PMID: 30907925; PMCID: PMC6503559.
    Citations: 7     Fields:    Translation:Humans
  17. Hantel A, Larson RA. Imatinib is still recommended for frontline therapy for CML. Blood Adv. 2018 12 26; 2(24):3648-3652. PMID: 30587493; PMCID: PMC6306882.
    Citations: 4     Fields:    Translation:Humans
  18. Hantel A, Gabster B, Cheng JX, Golomb H, Gajewski TF. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab. J Immunother Cancer. 2018 07 16; 6(1):73. PMID: 30012206.
    Citations: 19     Fields:    Translation:Humans
  19. Hantel A, Levine S, Siegler M. Creating Coherent Strategies to Combat the Crises of Opioid Scarcity and Abuse. J Clin Oncol. 2018 09 01; 36(25):2575-2577. PMID: 30001169.
    Citations:    Fields:    Translation:Humans
  20. Hantel A, Stock W, Kosuri S. Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician. Clin Lymphoma Myeloma Leuk. 2018 10; 18(10):636-647. PMID: 30006258.
    Citations: 5     Fields:    Translation:Humans
  21. Bestvina CM, Wroblewski KE, Daly B, Beach B, Chow S, Hantel A, Malec M, Huber MT, Polite BN. A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning. J Palliat Med. 2018 06; 21(6):846-849. PMID: 29649399.
    Citations: 3     Fields:    Translation:Humans
  22. Khan N, Hantel A, Knoebel RW, Artz A, Larson RA, Godley LA, Thirman MJ, Liu H, Churpek JE, King D, Odenike O, Stock W. Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia. Leuk Lymphoma. 2017 09; 58(9):1-7. PMID: 28278716.
    Citations: 9     Fields:    Translation:Humans
  23. Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med. 2016 11 24; 375(21):2023-2036. PMID: 27959731; PMCID: PMC5217532.
    Citations: 274     Fields:    Translation:HumansCTClinical Trials
  24. Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN. No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations. J Oncol Pract. 2016 10; 12(10):e901-e911. PMID: 27601514; PMCID: PMC5063186.
    Citations: 7     Fields:    Translation:Humans
  25. Hantel A, Olopade CO. Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use. Ann Intern Med. 2015 Jan 20; 162(2):141-2. PMID: 25322080.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  26. Marquez R, Hantel A, Lorenz R, Neistadt B, Wong J, Churpek JE, Mardini NA, Shaukat I, Gurbuxani S, Miller JL, Godley LA. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies. Leuk Lymphoma. 2014 Dec; 55(12):2945-6. PMID: 24628296.
    Citations: 12     Fields:    Translation:Humans
  27. Hantel A. A protocol and ethical framework for the distribution of rationed chemotherapy. J Clin Ethics. 2014; 25(2):102-15. PMID: 24972060.
    Citations: 3     Fields:    Translation:Humans
  28. Nabhan C, Smith SM, Helenowski I, Ramsdale E, Parsons B, Karmali R, Feliciano J, Hanson B, Smith S, McKoy J, Larsen A, Hantel A, Gregory S, Evens AM. Analysis of very elderly (=80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome. Br J Haematol. 2012 Jan; 156(2):196-204. PMID: 22084970.
    Citations: 25     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hantel's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (130)
Co-Authors (26)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.